A sampling of single- and multi-lumen extrusions in various materials and durometers from Aptyx. (Image courtesy Aptyx/Business Wire)
The acquisition is reported to bring an immediate expansion of extrusion technology and capacity to better serve Medtech innovation.
TEMPE, Ariz.—Aptyx, a global designer, developer, and manufacturer of complex devices and components for the life sciences industry, recently announced its strategic acquisition of Argos Corporation, a Massachusetts-based precision extrusion company with established expertise and technologies across materials and manufacturing processes.
With this acquisition, Aptyx will combine its growing precision extrusion portfolio and launch a Precision Extrusion Center of Excellence, adding immediate capacity, enhanced capabilities, and in-house engineering expertise for interventional innovation, the company said in a release.
“This marks another milestone in our growth strategy, further enhancing our ability to provide integrated expertise and innovation for our OEM Life Science customers,” said Aptyx President and CEO Gregg Tobin, in a statement. “This new center perfectly complements our Interventional Center of Excellence in Charlotte, where we have a long history of supporting complex transcatheter implants and delivery systems from early design to finished device manufacturing.”
According to Aptyx, it has long been recognized for its capabilities in extrusion, from core mandrel to specialty tubing for sleep, respiratory, and anesthesia applications. The new Precision Extrusion Center of Excellence builds on this foundation—expanding scale, technology, and catheter-grade precision to further support the development and manufacturing of complex interventional systems, the release stated.
The Center will support its customers with the following broad capabilities:
- High precision tubing with wall thicknesses from 0.001 inch and ID/OD tolerances to 0.0005 inch
- Quick-turn development and manufacturing in a controlled environment
- In-house tooling design to support speed, precision, and risk mitigation
- Broad range of materials and capabilities, including multi-lumen, precise taper tubing, micro extrusions, co-extrusion, multi-layered extrusion, and balloon tubing
- High-touch customer collaboration and assured quality
With the addition of the Boston-area Center of Excellence, Aptyx said it significantly expands its ability to serve the interventional and catheter-based device markets with speed, precision, and scalability.
The new facility adds depth to Aptyx’s already extensive portfolio of capabilities, including molding, extrusion, coating, and finished device assembly. As such, it is said to further enhance the “fully integrated design and manufacturing platform that supports customers from concept through commercialization.”
“We’re committed to conquering technical challenges and advancing what’s possible in medical tubing,” said Aptyx Director of Global Extrusion Patrick Daly, in the release. “This expansion deepens our extrusion expertise and enhances how we bring specialized strengths together across Aptyx to drive Medtech advancement.”
Argos is an ISO 13485–certified custom extrusion house with more than 25 years of experience in small-diameter medical tubing and precision thermoplastic profiles. The company produces microbore catheter shafts, liners, co-extrusions, multi-lumen, profile, striping, taper tubing, and heat-shrink and cut-to-order products for reflow, jacketing, and assembly. Its broad expertise across advanced polymers includes TPU, TPE, Pebax®, polycarbonate, nylons, polyolefins, PVDF, and other fluoropolymers, the release stated.